Intellia Therapeutics Overview

Life ScienceCompany

Where is Intellia Therapeutics headquartered?

Intellia Therapeutics is headquartered in Cambridge, Massachusetts.

What is Intellia Therapeutics’ revenue?

Intellia Therapeutics disclosed revenue of 58M USD for 2024 and 36M USD for 2023.

How many employees does Intellia Therapeutics have?

Intellia Therapeutics has 403 employees.

What sector is Intellia Therapeutics in?

Intellia Therapeutics is a life science company.

When was Intellia Therapeutics founded?

Intellia Therapeutics was founded in 2014.

Intellia Therapeutics

Intellia Therapeutics, Inc.

40 Erie Street, Suite 130,
Cambridge, Massachusetts 02139
United States,
(857) 285-6200
www.intelliatx.com

Intellia Therapeutics is a clinical-stage genome editing company, developing novel, potentially curative therapeutics leveraging CRISPR-based technologies. To fully realize the transformative potential of CRISPR-based technologies, Intellia is pursuing two primary approaches. The company’s in vivo programs use intravenously administered CRISPR as the therapy, in which proprietary delivery technology enables highly precise editing of disease-causing genes directly within specific target tissues. Intellia Therapeutics was founded in 2014 and is based in Cambridge, Massachusetts.


M&A Summary

Buy vs Sell

Year ≤ '20 '21 '22 '23 '24 '25 T
Buy (0.2/yr) # - - 1 - - - 1
Sell (0.0/yr) # - - - - - - 0
  1

Top M&A Advisors

Legal Deals
Latham & Watkins
1
Goodwin Procter
1
Finnegan, Henderson, Farabow, Garrett & Dunner
1

Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.